|
Volumn 25, Issue 2, 2001, Pages 244-250
|
Living donor lung transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACICLOVIR;
ANTIBIOTIC AGENT;
ANTIVIRUS AGENT;
AZATHIOPRINE;
CORTICOSTEROID;
COTRIMOXAZOLE;
CYCLOSPORIN;
GANCICLOVIR;
HYPERIMMUNE GLOBULIN;
IMMUNOSUPPRESSIVE AGENT;
PREDNISONE;
PROSTAGLANDIN E1;
ADULT;
ARTICLE;
CYSTIC FIBROSIS;
CYTOMEGALOVIRUS INFECTION;
FEMALE;
GRAFT REJECTION;
HUMAN;
INFECTIOUS COMPLICATION;
LOBECTOMY;
LUNG FUNCTION TEST;
LUNG SURGERY;
LUNG TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
PATIENT SELECTION;
PNEUMOCYSTIS PNEUMONIA;
QUALITY OF LIFE;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
ADULT;
CYSTIC FIBROSIS;
HUMANS;
LENGTH OF STAY;
LIVING DONORS;
LUNG TRANSPLANTATION;
PATIENT SELECTION;
SPIROMETRY;
|
EID: 0035053808
PISSN: 03642313
EISSN: None
Source Type: Journal
DOI: 10.1007/s002680020025 Document Type: Article |
Times cited : (37)
|
References (10)
|